Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
06/05/2013 | CN103127119A Pharmaceutical composition of piribedil/folic acid compound and purpose thereof |
06/05/2013 | CN103127118A Medicine composition of pramipexole/ folic acid compounds and functions thereof |
06/05/2013 | CN103127117A Pharmaceutical composition of levodopa/benserazide/folic acid compounds and purpose thereof |
06/05/2013 | CN103127116A Carbidopa/levodopa/folic acid compound medicine composition and use thereof |
06/05/2013 | CN103127105A Rhynchophylline application in drug preparing for preventing inflammation caused by excessive activation of astrocytes |
06/05/2013 | CN103127071A Application of Eryngiolide A in medicines curing Alzheimer disease |
06/05/2013 | CN103127059A Oral administration preparation composed of bilobalide B derivative and preparation method thereof |
06/05/2013 | CN103127046A Medicine containing diacetyl rhein compound and preparation method of medicine |
06/05/2013 | CN103127045A Composition containing gamma-aminobutyric acid and lycopene and preparation method thereof |
06/05/2013 | CN103127024A Stable disodium adenosine triphosphate tablet |
06/05/2013 | CN103127023A Duloxetine hydrochloride enteric-coated tablet and preparation method |
06/05/2013 | CN103127005A Preparation method of novel dopamine brain-targeting nano-particles |
06/05/2013 | CN103126997A Sustained release microsphere containing risperidone and risperidone analogues and preparation method thereof |
06/05/2013 | CN103126980A Gastrodin injection preparation and preparation method |
06/05/2013 | CN103126971A Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
06/05/2013 | CN103125928A Preparation method of gastrodia elata essence |
06/05/2013 | CN103125627A Smoking cessation tea |
06/05/2013 | CN102579852B Medicament for treating peripherical facial paralysis |
06/05/2013 | CN102552666B Chinese lavipeditum composition for treating insomnia |
06/05/2013 | CN102441103B Medicine for treating insomnia |
06/05/2013 | CN102440956B Preparation method of self-emulsified sumatriptan and salt preparation thereof |
06/05/2013 | CN102416012B Pharmaceutical composition for treating children's hyperactivity |
06/05/2013 | CN102370635B Application and preparation method of novel nardosinone |
06/05/2013 | CN102349907B Medicament for treating schizophrenia comprising cilostazol |
06/05/2013 | CN102344408B Double-effect anesthetic |
06/05/2013 | CN102337266B siRNAs and recombinant vector for inhibiting expression of Nogo A, MAG and OMgp genes, and application of siRNAs and recombinant vector |
06/05/2013 | CN102335386B Chinese medicinal composition for dispersing qi depression, promoting appetite, removing stagnation and stopping pain and preparation method thereof |
06/05/2013 | CN102309528B Preparation method of active substance capable of resisting neurodegenerative disease |
06/05/2013 | CN102266503B Sugar-free anemopyretic cold granules and preparation method thereof |
06/05/2013 | CN102258753B Chinese medicinal composition for treating poststroke depression and preparation method thereof |
06/05/2013 | CN102250048B 2-phenylselenomethyl-2,3-dihydrobenzofuran and preparation and application thereof |
06/05/2013 | CN102232953B Medicinal composition containing Esopiclone and preparation method thereof |
06/05/2013 | CN102106826B Aripiprazole solid preparation and preparation method thereof |
06/05/2013 | CN102106808B Solid preparation and preparation method thereof |
06/05/2013 | CN102083832B Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists |
06/05/2013 | CN101991612B Preparation method of haematococcus pluvialis extracts |
06/05/2013 | CN101978990B Schisandra extract and preparation method and application thereof |
06/05/2013 | CN101967168B Triterpenoid saponin derivative and preparation method and application thereof |
06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
06/05/2013 | CN101905015B Medicine capable of decomposing alcohol, preventing drunkenness and protecting liver |
06/05/2013 | CN101857591B Hydrochloric acid tiagabine crystal formations and preparation method thereof |
06/05/2013 | CN101802174B Cell growth method and pharmaceutical preparation for tissue repair and regeneration |
06/05/2013 | CN101780097B Application of DGPP (diacylglycerol pyrophosphate) in preparation of medicines for treating ischemic heart disease |
06/05/2013 | CN101711240B Sleep-improving agent |
06/05/2013 | CN101646351B Process of producing tomato paste |
06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
06/05/2013 | CN101496854B Chinese medicine sobering-up composition and Chinese medicine sobering-up beverage |
06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
06/05/2013 | CN101433565B Total alkaloid extract of seeds of harmel genus, and preparation thereof |
06/05/2013 | CN101352509B Velvet deerhorn liquor and preparation method thereof |
06/05/2013 | CN101244154B Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
06/05/2013 | CN101194965B Mastication tablet for treating headache and method for preparing the same |
06/05/2013 | CN101194963B Process for preparing medicine for treating headache |
06/05/2013 | CN101194961B Aerosol for treating headache and method for preparing the same |
06/05/2013 | CN101194959B Capsule for treating headache and method for preparing the same |
06/05/2013 | CN101194945B Tablet for treating headache and method for preparing the same |
06/05/2013 | CN101141964B Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
06/04/2013 | US8455550 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products |
06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
06/04/2013 | US8455502 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes |
06/04/2013 | US8455498 Inhibitors of histone deacetylase |
06/04/2013 | US8455489 Substituted pyrimidine compositions and methods of use |
06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
06/04/2013 | CA2542419C Use of glutamyl cyclase inhibitors in the treatment of familial british dementia and familial danish dementia |
06/04/2013 | CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
06/04/2013 | CA2457801C Streptococcus thermophilus strain and use thereof |
06/02/2013 | CA2761068A1 Novel dosage regimens and methods for treatment, prevention, and/or management of at least one cns disorder |
05/30/2013 | WO2013078395A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders |
05/30/2013 | WO2013078385A1 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid |
05/30/2013 | WO2013078123A1 Heterocyclic inhibitors of glutaminase |
05/30/2013 | WO2013077851A1 Immediate release abuse deterrent tablet |
05/30/2013 | WO2013076646A1 A new diaza-benzofluoranthene derivative as drug |
05/30/2013 | WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity |
05/30/2013 | WO2013076331A1 Phosphorylation on the thr-248 and/or thr-250 residues of transcription factor e2f4 as a therapeutic target in pathological processes associated with somatic polyploidy |
05/30/2013 | WO2013076101A1 Lactoferrin and the white matter |
05/30/2013 | WO2013075823A1 Transdermal therapeutic system comprising rotigotine and crystallization inhibitor |
05/30/2013 | WO2013075822A1 Transdermal therapeutic system (tts) with rotigotine |
05/30/2013 | WO2013075624A1 Glycine reuptake inhibitor and use thereof |
05/30/2013 | WO2013075621A1 Norepinephrine and selective serotonin receptor blocker and use thereof |
05/30/2013 | WO2013075459A1 Use of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma |
05/30/2013 | WO2013075227A1 β-GLUCOCEREBROSIDASE CHAPERONES |
05/30/2013 | WO2013054110A3 Compositions for binding to amyloid proteins |
05/30/2013 | WO2013034982A3 Immunomodulatory peptides for treatment of progressive neurodegenerative diseases |
05/30/2013 | US20130137727 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
05/30/2013 | US20130136798 Novel parenteral controlled release formulations of nsaid's |
05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
05/30/2013 | US20130136747 Anti-amyloid beta antibodies and their use |
05/30/2013 | CA2856386A1 Heterocyclic inhibitors of glutaminase |
05/30/2013 | CA2855854A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders |
05/30/2013 | CA2854252A1 1,4-dihydropyridine derivatives with hsp modulating activity |
05/30/2013 | CA2853764A1 Immediate release abuse deterrent tablet |
05/29/2013 | EP2597088A1 P2x4 receptor antagonist |
05/29/2013 | EP2597084A1 N-hydroxyformamide derivative and pharmaceutical containing same |
05/29/2013 | EP2596021A2 A method of treating alzheimer's disease |
05/29/2013 | EP2596020A2 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
05/29/2013 | EP2596019A2 A method of treating attention deficit hyperactivity disorder |
05/29/2013 | EP2596018A2 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
05/29/2013 | EP2595993A2 Tricyclic proteasome activity enhancing compounds |